Assertio Therapeutics
ASRT
#9522
Rank
HK$0.58 B
Marketcap
HK$6.05
Share price
-0.38%
Change (1 day)
-16.40%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -HK$0.21 Billion

According to Assertio Therapeutics 's latest financial reports the company's current earnings are HK$0.13 Billion. In 2024 the company made an earning of -HK$0.15 Billion, an increase over its 2023 earnings that were of -HK$1.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.21 Billion39.75%
2024 -HK$0.15 Billion-92.46%
2023 -HK$1.96 Billion-744.93%
2022 HK$0.30 B304.52%
2021 HK$74.9 M-132.53%
2020 -HK$0.24 Billion-81.97%
2019 -HK$1.28 Billion-253.57%
2018 HK$0.83 B-451.81%
2017 -HK$0.24 Billion-258.05%
2016 HK$0.14 B-138.59%
2015 -HK$0.39 Billion-121.01%
2014 HK$1.84 B2275.01%
2013 HK$77.65 M-133.45%
2012 -HK$0.24 Billion-141.87%
2011 HK$0.55 B1496.17%
2010 HK$34.73 M-121.23%
2009 -HK$0.17 Billion22.98%
2008 -HK$0.14 Billion-135.96%
2007 HK$0.36 B
2003 -HK$0.23 Billion
2000 -HK$60.22 Million43.5%
1999 -HK$41.97 Million58.6%
1998 -HK$26.46 Million580%
1997 -HK$3.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA